MiR-21 was also shown to be significantly increased in the plasma, peripheral blood CD4+ mononuclear cells, B cells, and T cells in the patients with SLE or splenic CD4+ T cells of MRL/lpr mice (2). This evidence concerns the gene CD4 and systemic lupus erythematosus.